Hester Biosciences Limited Market Cap ($208.11 Million)
Market Cap & Net Worth: Hester Biosciences Limited (HESTERBIO)
Hester Biosciences Limited market cap. Hester Biosciences Limited (NSE:HESTERBIO) has a market capitalization of $208.11 Million (Rs19.24 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #16173 globally and #827 in its home market, demonstrating a 9.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hester Biosciences Limited's stock price Rs2262.10 by its total outstanding shares 8506865 (8.51 Million). Also see HESTERBIO cash flow metrics for how efficiently the company converts equity into cash flow.
Hester Biosciences Limited Market Cap History (2015–2026)
Hester Biosciences Limited market cap history from 2015 to 2026. Data shows growth from $48.98 Million to $208.11 Million (12.27% CAGR). Check Hester Biosciences Limited stock quote for real-time trading data and today's change.
Hester Biosciences Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hester Biosciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Hester Biosciences Limited equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.05x
Hester Biosciences Limited's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.54x
Hester Biosciences Limited's market cap is 0.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $63.36 Million | $1.01 Billion | $188.83 Million | 0.06x | 0.34x |
| 2017 | $165.31 Million | $1.23 Billion | $234.48 Million | 0.13x | 0.71x |
| 2018 | $101.44 Million | $1.36 Billion | $256.21 Million | 0.07x | 0.40x |
| 2019 | $130.76 Million | $1.78 Billion | $415.67 Million | 0.07x | 0.31x |
| 2020 | $154.74 Million | $1.83 Billion | $291.71 Million | 0.08x | 0.53x |
| 2021 | $230.27 Million | $2.14 Billion | $344.30 Million | 0.11x | 0.67x |
| 2022 | $163.67 Million | $2.35 Billion | $393.20 Million | 0.07x | 0.42x |
| 2023 | $133.80 Million | $2.66 Billion | $266.27 Million | 0.05x | 0.50x |
| 2024 | $220.74 Million | $3.05 Billion | $188.89 Million | 0.07x | 1.17x |
| 2025 | $147.17 Million | $3.11 Billion | $274.88 Million | 0.05x | 0.54x |
Competitor Companies of HESTERBIO by Market Capitalization
Companies near Hester Biosciences Limited in the global market cap rankings as of November 4, 2026. Also see Hester Biosciences Limited (HESTERBIO) total assets for a full breakdown of the balance sheet.
Key companies related to Hester Biosciences Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Hester Biosciences Limited (2015–2026)
Market capitalization of Hester Biosciences Limited from 2015 to today. Between 2015 and today, Hester Biosciences Limited's market cap moved from $48.98 Million to $ 208.11 Million, with a yearly change of 12.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs208.11 Million | +41.41% |
| 2025 | Rs147.17 Million | -33.33% |
| 2024 | Rs220.74 Million | +64.98% |
| 2023 | Rs133.80 Million | -18.25% |
| 2022 | Rs163.67 Million | -28.92% |
| 2021 | Rs230.27 Million | +48.81% |
| 2020 | Rs154.74 Million | +18.34% |
| 2019 | Rs130.76 Million | +28.91% |
| 2018 | Rs101.44 Million | -38.64% |
| 2017 | Rs165.31 Million | +160.92% |
| 2016 | Rs63.36 Million | +29.35% |
| 2015 | Rs48.98 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Hester Biosciences Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $208.11 Million USD |
| MoneyControl | $208.11 Million USD |
| MarketWatch | $208.11 Million USD |
| marketcap.company | $208.11 Million USD |
| Reuters | $208.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hester Biosciences Limited
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more